Paratek Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use…

Biotechnology
US, Boston [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Paratek Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Paratek Pharmaceuticals, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Paratek Pharmaceuticals, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of PRTK's Analysis
CIK: 1178711 CUSIP: 699374302 ISIN: US6993743029 LEI: - UEI: -
Secondary Listings
PRTK has no secondary listings inside our databases.